Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axsome Thera One World Trade Center 22nd Floor NEW YORK NY 10007 USA

www.axsome.com Employees: 683 P: 212-332-3241 F: 212-320-0245

Sector:

Medical

Description:

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

Key Statistics

Overview:

Market Capitalization, $K 5,004,840
Enterprise Value, $K 4,870,200
Shares Outstanding, K 49,236
Annual Sales, $ 385,690 K
Annual Net Income, $ -287,220 K
Last Quarter Sales, $ 121,460 K
Last Quarter Net Income, $ -59,410 K
EBIT, $ -263,900 K
EBITDA, $ -253,300 K
60-Month Beta 0.48
% of Insider Shareholders 22.40%
% of Institutional Shareholders 81.49%
Float, K 38,207
% Float 77.60%
Short Volume Ratio 0.66

Growth:

1-Year Return 32.82%
3-Year Return 150.12%
5-Year Return 25.54%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -95.52%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.80 on 05/05/25
Next Earnings Date 08/04/25
Earnings Per Share ttm -4.34
EPS Growth vs. Prev Qtr 16.67%
EPS Growth vs. Prev Year 26.61%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AXSM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -272.80%
Return-on-Assets % -36.69%
Profit Margin % -74.47%
Debt/Equity 3.41
Price/Sales 12.85
Price/Cash Flow N/A
Price/Book 93.18
Book Value/Share 1.08
Interest Coverage -42.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar